TRML β€” TOURMALINE BIO INC

Ownership history in Chicago Capital Management, LLC  Β·  1 quarter on record

This page tracks every 13F SEC filing in which Chicago Capital Management, LLC reported a position in TOURMALINE BIO INC (TRML). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
4.81% (2025 Q3)
πŸ“Š Avg. % of fund
4.81%
πŸ“… First filed
2025 Q3
πŸ“… Last filed
2025 Q3
⏱ Quarters held
1
% of Fund (quarterly)
πŸ“‹ Quarterly Holdings History 1 quarter  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 112,406 β€” β€” 4.81% $5.4M β€”

🏒 Other funds also holding TRML

As of 2025 Q3 β€” sorted by position size

Qiming U.S. Ventures Management, LLC 3Y 63.76% PFIZER INC 13.91% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 13.27% QVT Financial LP 3Y 7Y 7.27% TCG Crossover Management, LLC 3Y 3.09% Vivo Capital, LLC 3Y 7Y 2.28% HARVEST MANAGEMENT LLC 3Y 7Y 2.07% Versor Investments LP 3Y 7Y 1.91% NEXPOINT ASSET MANAGEMENT, L.P. 3Y 1.89% TIG Advisors, LLC 3Y 7Y 1.76%
← Back to Chicago Capital Management, LLC Holdings